Andrew L Warshaw Selected Research

folfirinox

11/2023	Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer.
11/2021	Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy.
1/2021	Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy.
7/2020	FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines.
1/2019	Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges.
1/2019	Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
1/2015	Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew L Warshaw Research Topics

Disease

42	Neoplasms (Cancer) 12/2023 - 01/2002
24	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2002
21	Adenocarcinoma 11/2023 - 10/2003
11	Pancreatic Fistula (Pancreatic Fistulas) 10/2019 - 10/2002
11	Pancreatitis 11/2015 - 01/2002
7	Neoplasms, Cystic, Mucinous, and Serous 03/2022 - 07/2007
4	Carcinoma (Carcinomatosis) 01/2018 - 11/2009
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 03/2008
4	Chronic Pancreatitis 12/2016 - 11/2003
3	Neoplasm Metastasis (Metastasis) 10/2017 - 12/2003
3	Abscess 11/2010 - 05/2007
2	Pancreatic Intraductal Neoplasms 06/2020 - 12/2016
2	Wound Infection (Wound Infections) 12/2019 - 12/2018
2	Cysts 11/2017 - 05/2009
2	Metaplasia 12/2016 - 03/2007
2	Primitive Neuroectodermal Tumors (PNET) 12/2016 - 03/2008
2	Atrial Fibrillation 11/2010 - 06/2005
2	Sepsis (Septicemia) 11/2010 - 07/2006
2	Fistula 10/2008 - 05/2008
2	Hemorrhage 05/2008 - 05/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2007 - 06/2005
2	Hypertension (High Blood Pressure) 05/2006 - 06/2005
1	Thrombosis (Thrombus) 11/2023
1	Residual Neoplasm 01/2020
1	Venous Thromboembolism 01/2020
1	Pathologic Complete Response 01/2020
1	Pancreatic Diseases (Pancreatic Disease) 05/2019
1	Hypophosphatemia 01/2019
1	Vomiting 12/2018
1	Nausea 12/2018
1	Cholangitis 04/2018
1	Gastric Outlet Obstruction 04/2018
1	Gastrinoma 11/2017

Drug/Important Bio-Agent (IBA)

7	folfirinoxIBA 11/2023 - 01/2015
5	MucinsIBA 12/2016 - 02/2009
4	AntigensIBA 01/2022 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 07/2020 - 11/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2002
3	Colloids (Colloid)IBA 01/2018 - 12/2011
3	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 03/2008
3	Peroxidase (Myeloperoxidase)IBA 07/2006 - 01/2002
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2005 - 12/2003
3	TrypsinIBA 01/2005 - 01/2002
2	N-acetyltalosaminuronic acid (NAT)IBA 04/2023 - 10/2019
2	CarbohydratesIBA 01/2022 - 12/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 07/2020
2	CollagenIBA 12/2020 - 01/2017
2	ChromatinIBA 12/2020 - 08/2016
2	LigandsIBA 01/2020 - 10/2003
2	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 06/2005
2	Amylases FDA Link 08/2015 - 05/2008
2	BilirubinIBA 06/2015 - 06/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 12/2003
2	Peptides (Polypeptides)IBA 01/2011 - 12/2003
2	Contrast MediaIBA 01/2011 - 01/2002
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2007 - 06/2005
2	Matrix Metalloproteinase InhibitorsIBA 05/2002 - 01/2002
2	Matrix Metalloproteinases (MMPs)IBA 05/2002 - 01/2002
1	ABO Blood-Group SystemIBA 03/2022
1	Trinitrotoluene (TNT)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	CPI203IBA 12/2020
1	130-nm albumin-bound paclitaxelIBA 07/2020
1	Gemcitabine FDA Link 07/2020
1	Phosphates (Orthophosphate)IBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 12/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018
1	GastrinsIBA 11/2017
1	Trefoil FactorsIBA 12/2016
1	Trefoil Factor-2IBA 12/2016
1	Gastric MucinsIBA 12/2016
1	Histones (Histone)IBA 12/2016
1	ParaffinIBA 12/2016
1	Small Interfering RNA (siRNA)IBA 08/2016
1	Bromodeoxyuridine (BrdU)IBA 07/2015

Therapy/Procedure

18	Pancreatectomy 12/2023 - 10/2002
12	Therapeutics 11/2023 - 05/2002
10	Neoadjuvant Therapy 11/2023 - 01/2015
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2005
6	Pancreaticoduodenectomy 05/2020 - 11/2003
3	Splenectomy 05/2019 - 05/2007
3	Radiotherapy 12/2013 - 01/2005
2	Stents 12/2019 - 04/2018
2	Laparotomy 10/2017 - 05/2002
2	Debridement 11/2015 - 02/2008
2	Length of Stay 01/2014 - 07/2007
2	Immunotherapy 09/2012 - 01/2005
2	Patient Discharge 10/2009 - 05/2008
1	Postoperative Care 01/2023
1	Lasers (Laser) 01/2021
1	Adjuvant Chemotherapy 05/2020
1	Aftercare (After-Treatment) 01/2020
1	Hepatectomy 01/2019
1	Anesthesia 12/2018